A theoretical model for the production of Ac-225 for cancer therapy by neutron capture transmutation of Ra-226

被引:8
|
作者
Melville, G. [1 ]
Melville, P. [1 ]
机构
[1] St George Canc Care Ctr, Ctr Expt Radiat Oncol, Kogarah, NSW, Australia
关键词
Ra-225; Ac-225; Ra-226; Neutron irradiation; Nuclear reactor; Targeted alpha therapy; PHOTON-INDUCED TRANSMUTATION;
D O I
10.1016/j.apradiso.2012.09.019
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Radium needles that were once implanted into tumours as a cancer treatment are now obsolete and constitute a radioactive waste problem, as their half-life is 1600 years. We are investigating the reduction of radium by transmutation by bombarding Ra-226 with high-energy neutrons from a neutron source to produce Ra-225 and hence Ac-225, which can be used as a generator to produce Bi-213 for use in 'Targeted Alpha Therapy' for cancer. This paper examines the possibility of producing Ac-225 by neutron capture using a theoretical model in which neutron energy is convoluted with the corresponding neutron cross sections of Ra-226. The total integrated yield can then be obtained. This study shows that an intense beam of high-energy neutrons could initiate neutron capture on Ra-226 to produce Ra-225 and hence practical amounts of Ac-225 and a useful reduction of Ra-226. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 50 条
  • [21] Efficacy and Safety of Ac-225 PSMA Radio Ligand Therapy in Metastatic Prostate Cancer. A Systematic Review and Metanalysis
    Parida, Girish Kumar
    Panda, Raj Abhisek
    Bishnoi, Komal
    Agrawal, Kanhaiyalal
    MEDICAL PRINCIPLES AND PRACTICE, 2023, 32 (03) : 178 - 191
  • [22] Research and Development for Cyclotron Production of 225Ac from 226Ra-The Challenges in a Country Lacking Natural Resources for Medical Applications
    Higashi, Tatsuya
    Nagatsu, Kotaro
    Tsuji, Atsushi B.
    Zhang, Ming-Rong
    PROCESSES, 2022, 10 (06)
  • [23] Neutron dosimetry on phantom model of pancreatic cancer for boron neutron capture therapy
    Yanagie, H.
    Sakurai, Y.
    Ogura, K.
    Kobayashi, T.
    Furuya, Y.
    Sugiyama, H.
    Hisa, T.
    Ishikawa, M.
    Amemiya, K.
    Takahashi, H.
    Kobayashi, H.
    Tago, M.
    Masunaga, S.
    Ono, K.
    Nakagawa, K.
    Nakzawa, M.
    Eriguchi, M.
    KURRI Progress Report, 2003,
  • [24] Clinical experience with PSMA-Actinium-225 (Ac-225) radioligand therapy (RLT) in end-stage metastatic castration-resistant prostate cancer (mCRPC) patients.
    van der Doelen, Maarten Johannes
    Mehra, Niven
    Smits, Minke
    van Oort, Inge M.
    Janssen, Marcel J. R.
    Haberkorn, Uwe
    Kratochwil, Clemens
    Gerritsen, Winald
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [25] Evaluation of the production amount of 225Ac and its uncertainty through the 226Ra(n,2n) reaction in the experimental fast reactor Joyo
    Sasaki, Yuto
    Sano, Aaru
    Sasaki, Shinji
    Iwamoto, Nobuyuki
    Ouchi, Kazuki
    Kitatsuji, Yoshihiro
    Takaki, Naoyuki
    Maeda, Shigetaka
    JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, 2024, 61 (04) : 509 - 520
  • [26] Evaluation of the production amount of 225Ac and its uncertainty through the 226Ra(n,2n) reaction in the experimental fast reactor Joyo
    Sasaki, Yuto
    Sano, Aaru
    Sasaki, Shinji
    Iwamoto, Nobuyuki
    Ouchi, Kazuki
    Kitatsuji, Yoshihiro
    Takaki, Naoyuki
    Maeda, Shigetaka
    JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, 2023,
  • [27] Actinium (Ac-225) Rosopatamab tetraxetan (Ac-RT) therapy in metastatic castration resistant prostate cancer (mCRPC); Radiation dosimetry, hematological toxicity, and dose-limiting toxicity (DLT)
    Vallabhajosula, Shankar
    Tagawa, Scott
    Osborne, Joseph
    Nauseef, Jones
    Fajardo, Andres Ricaurte
    Castellanos, Sandra
    Davidson, Zachary
    Bander, Neil H.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [28] Radiation Dosimetry of Actinium (Ac-225) Rosopatamab Tetraxetan (Ac-RT): Anti-PSMA antibody labeled with an alpha emitter for targeted therapy of metastatic castration resistant prostate cancer (mCRPC)
    Vallabhajosula, Shankar
    He, Bin
    Tagawa, Scott
    Bander, Neil H.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [29] Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model
    Kreimann, EL
    Itoiz, ME
    Longhino, J
    Blaumann, H
    Calzetta, O
    Schwint, AE
    CANCER RESEARCH, 2001, 61 (24) : 8638 - 8642
  • [30] Evaluation of neutron dosimetry on pancreatic cancer phantom model for application of intraoperative boron neutron-capture therapy
    Yanagie, Hironobu
    Sakurai, Yosiyuki
    Ogura, Koichi
    Kobayashi, Tooru
    Furuya, Yoshitaka
    Sugiyama, Hirotaka
    Kobayashi, Hisao
    Ono, Koji
    Nakagawa, Keiichi
    Takahashi, Hiroyuki
    Nakazawa, Masaharu
    Eriguchi, Masazumi
    BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (08) : 505 - 514